Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients
This study has been completed.
Study NCT00752518 Information provided by Janssen Pharmaceutical K.K.
First Received on September 11, 2008. Last Updated on May 16, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Neoplasms, Plasma Cell
More general conditions related to this trial
Blood Protein Disorders
Immune System Diseases
Neoplasms by Histologic Type
Interventions listed in this trial
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Janssen Pharmaceutical K.K.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers